A phase I/II study investigating the pharmacokinetics, safety, and hormone concentrations of single and repeated administration of LF111 (drospirenone) in healthy Japanese women
Latest Information Update: 24 Apr 2024
At a glance
- Drugs Drospirenone (Primary)
- Indications Pregnancy
- Focus Adverse reactions; Pharmacokinetics
- 24 Apr 2024 Planned initiation date changed from 18 Jan 2021 to NULL.
- 23 Apr 2024 New trial record
- 01 Apr 2024 Results evaluating the pharmacokinetics, pharmacodynamics, and safety of drospirenone as an oral contraceptive in Japanese women, published in the Journal of Obstetrics and Gynaecology Research